The results showed that B16-LX/IL-24 could not provide any increased preventive effects against EL-4 cells, as compared with irradiated B16-immunized mice (Figure 4C), suggesting that the antitumor response induced by LX/IL-24-modified tumor cells was specific to autologous tumor. This evidence concerns the gene IL24 and neoplasm.